This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Kohlberger, P. D. Articles by Kieback, D. G. Search for Related Content PubMed PubMed Citation Articles by Kohlberger, P. D. Articles by Joura, E. A. Articles by Bancher, D. Articles by Gitsch, G. Articles by Breitenecker, G. Articles by Kieback, D. G. Social Bookmarking                   What's this?

Evidence of Androgen Receptor Expression in Lichen Sclerosus: An Immunohistochemical Study

Department of Obstetrics and Gynecology, Freiburg University Medical Center, Freiburg, Germany; Departments of Obstetrics and Gynecology, and Pathology, University Medical Center, Vienna, Austria; pkohlb{at}frk1.ukl.uni-freiburg.de

Elmar A. Joura, MD

Dagmar Bancher, MD

Gerald Gitsch, MD

Gerhard Breitenecker, MD

Dirk G. Kieback, MD

Department of Obstetrics and Gynecology, Freiburg University Medical Center, Freiburg, Germany; Departments of Obstetrics and Gynecology, and Pathology, University Medical Center, Vienna, Austria

Objective: While topical androgen administration is widely used in the treatment of lichen sclerosus of the vulva, localization and level of expression of androgen receptor (AR) have not been described previously.

Methods: Thirty-nine paraffin-embedded punch biopsies of patients with lichen sclerosus of the vulva were examined. Androgen receptor, estrogen receptor (ER), and progesterone receptor (PR) expression in lichen sclerosus and in normal vulvar skin were investigated by immunohistochemistry.

Results: Five tissue specimens (12.8%) of lichen sclerosus showed nuclear staining with anti-AR in the parabasal cell layers of the epidermis. Median age of patients with positive nuclear staining for AR versus women without AR expression was 71 (range, 63-78) and 66.5 (range, 38-91) years, respectively. Estrogen receptor expression was present in only one patient. Nuclear staining reaction for PR expression was absent in all cases. Four of the five AR-positive women reported no complaints and therefore received no topical testosterone therapy.

Conclusion: Our results suggest a lack of complaints in AR-positive lichen sclerosus patients. Our findings could justify a larger study comparing symptoms of patients with and without AR expression.

Key Words: Androgen receptor • lichen sclerosus • immunohistochemistry

Journal of the Society for Gynecologic Investigation, Vol. 5, No. 6, 331-333 (1998)
DOI: 10.1177/107155769800500610


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?